NCT07273292Not yet recruiting
Autonomic Dysfunction in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis : A Comparative Study
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
To compare the frequency and patterns of autonomic dysfunction in patients with NMOSD and MS, and to investigate its correlations with clinical disability, radiological findings, fatigue, and quality of life parameters
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 1 Oct 2025
- Start date
- 20 Jan 2026
- Primary completion date
- Sept 2028
- Lead sponsor
- Mohamed Moshref abd alsattar
- NCT number
- NCT07273292
What you commit to
- Study type: Observational
- Planned participants: 100
- From 20 Jan 2026 to the primary completion date, Sept 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medications known to interfere with autonomic testing.
Other illness
- Comorbidities affecting autonomic function (e.g., diabetes, Parkinsonism).
- Cognitive impairment precluding questionnaire completion.
Who the study is looking for
- Adult patients (≥18 years , both sexes.
- Confirmed diagnosis of NMOSD according to the 2015 International Consensus Criteria.
- Confirmed diagnosis of RRMS according to the 2024 McDonald diagnostic criteria.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.